Edwin Jauregui, MD

Riesgo de fractura S.A
Bogotá, Colombia

Internist and Rheumatologist
Master in clinical epidemiology
Clinical Chief at Riesgo de fractura S.A

Presentation(s):

• 1041: Associated Factors and Direct Cost Analysis of Dose Reduction and Discontinuation of Biological Therapies in Rheumatoid Arthritis and Spondyloarthritis: Findings from a Colombian Cohort Within the Framework of an Integrated Management Model

  Monday, October 27, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): AbbVie/Abbott: Consultant (Terminated, August 4, 2025), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, August 4, 2025); Biopas: Consultant (Terminated, August 4, 2025), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, August 4, 2025); Novartis: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)